A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder

Clinical trial NCT06618118 · TERMINATED

Trial details

NCT number: NCT06618118
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2024-10-23
Primary completion: 2025-09-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.